BBNX (STOCKS)
Beta Bionics, Inc. Common Stock
$10.420000
+1.560000 (+17.61%)
Prev close: $8.860000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Sean Thomas Saint
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $472.23M
- Employees
- 409
- P/E (TTM)
- -6.33
- P/B (TTM)
- 1.37
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
8
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.29 | $-0.42 | +0.1338 | +31.57% |
|
Sep 2025 (Q3)
|
$-0.33 | $-0.44 | +0.1123 | +25.39% |
|
Jun 2025 (Q2)
|
$-0.39 | $-0.46 | +0.0682 | +14.88% |
|
Mar 2025 (Q1)
|
$-0.93 | $-0.49 | -0.4445 | -91.56% |
Financial Statements
| Revenues | $88.57M |
| Benefits Costs and Expenses | $0.00 |
| Cost Of Revenue | $40.29M |
| Costs And Expenses | $157.16M |
| Gross Profit | $48.28M |
| Nonoperating Income/Loss | -$9.25M |
| Operating Expenses | $116.88M |
| Research and Development | $33.87M |
| Other Operating Expenses | $83.00M |
| Operating Income/Loss | -$68.59M |
| Income/Loss From Continuing Operations After Tax | -$77.84M |
| Income/Loss From Continuing Operations Before Tax | $88.57M |
| Net Income/Loss | -$77.84M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$77.84M |
| Net Income/Loss Available To Common Stockholders, Basic | -$77.84M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.26 |
| Diluted Earnings Per Share | -$4.26 |
| Basic Average Shares | 39,394,700 |
| Diluted Average Shares | 39,394,700 |
| Assets | $330.05M |
| Current Assets | $270.03M |
| Inventory | $20.37M |
| Prepaid Expenses | $6.45M |
| Other Current Assets | $243.21M |
| Noncurrent Assets | $60.02M |
| Fixed Assets | $7.39M |
| Other Non-current Assets | $52.64M |
| Liabilities | $35.29M |
| Current Liabilities | $25.39M |
| Accounts Payable | $4.46M |
| Wages | $11.01M |
| Other Current Liabilities | $9.92M |
| Noncurrent Liabilities | $9.90M |
| Equity | $294.76M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $294.76M |
| Liabilities And Equity | $330.05M |
| Net Cash Flow From Operating Activities | -$56.58M |
| Net Cash Flow From Operating Activities, Continuing | -$56.58M |
| Net Cash Flow From Investing Activities | -$193.13M |
| Net Cash Flow From Investing Activities, Continuing | -$193.13M |
| Net Cash Flow From Financing Activities | $270.71M |
| Net Cash Flow From Financing Activities, Continuing | $270.71M |
| Net Cash Flow | $21.00M |
| Net Cash Flow, Continuing | $21.00M |
| Comprehensive Income/Loss | -$77.55M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$77.55M |
| Other Comprehensive Income/Loss | -$77.55M |